Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Poljak

Showing results (301-310 of 350) with videos related to

Pageof 35
Sort By:
Cell Reports|April 29, 2026
The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcriptsClément R Bouton, Grega Gimpelj Domjanič, María José Lista, et al.
Emerging Infectious Diseases|January 26, 2023
Intrahost Monkeypox Virus Genome Variation in Patient with Early Infection, Finland, 2022Hanna Vauhkonen, Hannimari Kallio-Kokko, Eija Hiltunen-Back, et al.
Cancer Cytopathology|September 11, 2015
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesionPaolo Giorgi Rossi, Guglielmo Ronco, Joakim Dillner, et al.
AIDS (London, England)|September 21, 2022
HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trendsLuka Jovanovic, Marina Siljic, Valentina Cirkovic, et al.
Intensive Care Medicine|December 31, 2017
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistanceJan J De Waele, Murat Akova, Massimo Antonelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
Radiology and Oncology|September 15, 2018
Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approachesUrska Ivanus, Tine Jerman, Alenka Repse Fokter, et al.
Plos One|June 15, 2010
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropeVictoria L Demetriou, David A M C van de Vijver, Ioanna Kousiappa, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Pageof 35

Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Cell Reports|April 29, 2026
The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcriptsClément R Bouton, Grega Gimpelj Domjanič, María José Lista, et al.
Emerging Infectious Diseases|January 26, 2023
Intrahost Monkeypox Virus Genome Variation in Patient with Early Infection, Finland, 2022Hanna Vauhkonen, Hannimari Kallio-Kokko, Eija Hiltunen-Back, et al.
Cancer Cytopathology|September 11, 2015
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesionPaolo Giorgi Rossi, Guglielmo Ronco, Joakim Dillner, et al.
AIDS (London, England)|September 21, 2022
HIV-1 subtype B spread through cross-border clusters in the Balkans: a molecular analysis in view of incidence trendsLuka Jovanovic, Marina Siljic, Valentina Cirkovic, et al.
Intensive Care Medicine|December 31, 2017
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistanceJan J De Waele, Murat Akova, Massimo Antonelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
2020 list of human papillomavirus assays suitable for primary cervical cancer screeningMarc Arbyn, Marie Simon, Eliana Peeters, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
Radiology and Oncology|September 15, 2018
Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approachesUrska Ivanus, Tine Jerman, Alenka Repse Fokter, et al.
Plos One|June 15, 2010
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropeVictoria L Demetriou, David A M C van de Vijver, Ioanna Kousiappa, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Pageof 35